Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing.
In this study, patients with obstructive hypertrophic cardiomyopathy (HC) were treated with dual-chamber pacemaker therapy. Long-term follow-up analysis showed that dual-chamber pacemaker therapy in selected patients resulted in a significant reduction in symptoms and in the left ventricular outflow tract gradient, which was maintained up to 10 years after implantation. Dual-chamber pacing is of potential long-term benefit in selected groups of patients with obstructive HC.
Megevand
Angelique
A
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
Ingles
Jodie
J
Richmond
David R
DR
Semsarian
Christopher
C
D000328:Adult; D002312:Cardiomyopathy, Hypertrophic / Q000473:pathology* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D016896:Treatment Outcome; D016277:Ventricular Function, Left